Company page

Biocryst Pharmaceuticals, Inc.

Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.